Article Information
Volume 23, Issue 21, pp. 6555-6566
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 13, 2017
- Revision received July 5, 2017
- Accepted August 1, 2017
- Published first August 8, 2017.
Article Versions
- Previous version (August 8, 2017 - 06:37).
- Previous version (September 27, 2017 - 07:10).
- You are viewing the most recent version of this article.
Copyright & Usage
©2017 American Association for Cancer Research.
Author Information
- Ada W.Y. Leung1,2,*,
- Chansey J. Veinotte3,
- Nicole Melong3,
- Min Hee Oh4,5,
- Kent Chen1,5,
- Katey S.S. Enfield4,
- Ian Backstrom1,
- Corinna Warburton1,
- Donald Yapp1,6,
- Jason N. Berman3,7,
- Marcel B. Bally1,2,6,8, and
- William W. Lockwood2,4,5
- 1Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
- 2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- 3Department of Pediatrics, Dalhousie University/IWK Health Centre, Halifax, Nova Scotia, Canada.
- 4Integrative Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.
- 5The Interdisciplinary Oncology Program, University of British Columbia, Vancouver, British Columbia, Canada.
- 6Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
- 7Department of Microbiology & Immunology and Pathology, Life Sciences Research Institute, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
- 8Centre for Drug Research and Development, Vancouver, British Columbia, Canada.
- ↵*Corresponding Author:
Ada Wai Yin Leung, 5.304 Experimental Therapeutics, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada. Phone: 604-678-8000, ext. 7024; Fax: 604-675-8183; E-mail: aleung{at}bccrc.ca